SCHEMBL7004615

SCHEMBL7004615

Cc1cccc(C)c1N1[CH]CN(CC(O)COc2cccc3cnccc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.51
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAPT P10636 8/20 0.48
TDP1 Q9NUW8 4/20 0.48
MAPK1 P28482 4/20 0.48
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 4/20 0.47
ALOX15 P16050 2/20 0.47
TSHR P16473 2/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
HIF1A Q16665 2/20 0.46
ADRB1 P08588 2/20 0.46
NR1I2 O75469 1/20 0.46
NR3C1 P04150 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5226594 0.78 CYP3A4 (0.68) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL9181688 0.76 KMT2A (0.58) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL9179657 0.73 MAPT (0.54) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL27535690 0.72 KCNA3 (0.55) LMNAMEN1KMT2ASMN1; SMN2TDP1
SCHEMBL9179528 0.72 ABCB1 (0.54) LMNAMEN1KMT2AMAPTTDP1
SCHEMBL7007007 0.71 CYP3A4 (0.44) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL7711797 0.71 MEN1 (0.48) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL7705260 0.70 PRMT5 (0.44) LMNAMEN1KMT2ASMN1; SMN2TDP1
SCHEMBL7711594 0.70 LMNA (0.47) LMNAMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL7600203 0.70 KMT2A (1.00) LMNAMEN1KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339701-A1 HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2003-09-03 EP disclosed
WO-2002064576-A1 HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2002-08-22 WO disclosed